Could a flu drug help stroke patients recover?
NCT ID NCT05140148
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether amantadine, a drug already used for flu and Parkinson's, can help people recover after a stroke. Sixty adults who had an ischemic or hemorrhagic stroke will receive either amantadine or a placebo for one month. Researchers will track side effects and measure recovery using patient questionnaires over three months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Amantadine
- What this could lead to
- If it works, this could point toward a treatment to improve recovery after a stroke.
- What could go wrong
- This is a small, early-phase trial with only 60 participants. The drug may not show benefit over placebo, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Hospital of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentle ear zap supercharge stroke rehab at home?
- Can virtual games retrain the brain to restore balance?
- A Pocket-Sized MRI for strokes? new device put to the test
- Can sound waves reawaken the brain after stroke?
- Does a dedicated stroke unit boost recovery after a first stroke?
- Could a wireless patch replace wires on tiny heads? a NICU trial puts it to the test